This discovery not only emphasizes the close relationship between the expression of RAB5B and the immune infiltration of tumor cells, but also suggests that it may have an important impact on the prognosis of patients, thus opening up new potential targets for the development of immunomodulatory drugs. This evidence concerns the gene RAB5B and neoplasm.